# Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

> **NCT01149486** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Losartan potassium/Hydrochlorothiazide
- **DRUG:** Hyzaar®

## Key facts

- **NCT ID:** NCT01149486
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-02
- **Final completion:** 2004-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149486, "Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01149486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*